Potential of Anti-CMV Immunoglobulin Cytotect CP^® In Vitro and Ex Vivo in a First-Trimester Placenta Model

Background: Congenital CMV infection is the leading cause of neonatal neurological deficit. We herein studied in vitro and ex vivo the potential of the hyperimmune globulin Cytotect CP^® (Biotest, Germany) for congenital infection prevention and treatment. Methods: In vitro neutralization...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Perrine Coste Mazeau, Chloé Jacquet, Clotilde Muller, Mathis Courant, Chahrazed El Hamel, Thierry Chianea, Sébastien Hantz, Sophie Alain
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2022-03-01
Reeks:	Microorganisms
Onderwerpen:	congenital cytomegalovirus hyperimmune immunoglobulins Cytotect CP<sup>®</sup>
Online toegang:	https://www.mdpi.com/2076-2607/10/4/694
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!